Back to top
more

Foundation Medicine, Inc. (FMI)

(Real Time Quote from BATS)

$137.00 USD

137.00
NA

-0.05 (-0.04%)

Updated Jul 31, 2018 03:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

NA

Industry: NA

Better trading starts here.

Zacks News

Sweta Killa headshot

Should First Trust Small Cap Growth AlphaDEX Fund (FYC) Be on Your Investing Radar?

Style Box ETF report for FYC

    Pharma Stock Roundup: PTCT Unveils Promising Data, RHHBY to Acquire Rest of FMI

    Roche (RHHBY) will buy the remaining stake in Foundation Medicine for $2.4 billion. PTC Therapeutics (PTCT) presents encouraging preliminary data from an early-stage study in spinal muscular atrophy.

      TESARO (TSRO) Stock Up on Rumors of Buyout Offer From Roche

      Shares of TESARO (TSRO) rise on speculation of an acquisition bid from Roche.

        Will Roche's (RHHBY) Acquisition Spree Revive the Top Line?

        Roche (RHHBY) is looking to boost its portfolio with some strategic acquisitions and we expect further activities on this front.

          Company News For Jun 20, 2018

          Companies in the news are: T,FMI,COTV,SRPT

            Roche to Buy Rest of Foundation Medicine for $2.4 billion

            Roche inks a deal with Foundation Medicine to acquire the remaining shares of Foundation Medicine, not already owned by it for a total consideration of $2.4 billion.

              Sweta Killa headshot

              5 Top Performing Stocks of the Best ETF of May

              Inside the best performing stocks of the top ETF of May - ARKG.

                Company News For Dec 5, 2017

                Companies In The News are: AET,BGC,CVS,FMI,EXAC

                  Options Traders Expect Huge Moves in Foundation Medicine (FMI) Stock

                  Investors in Foundation Medicine (FMI) need to pay close attention to the stock based on moves in the options market lately.

                    Sweta Killa headshot

                    ETF Winner of 1H17 and its Top 5 Stocks

                    Inside the top performing ETF of the first half of 2017.

                      Foundation Medicine (FMI) Jumps: Stock Adds 10.6% in Session

                      Foundation Medicine, Inc. (FMI) moved big last session, as its shares rose over 10% on the day.

                        Is the Options Market Predicting a Spike in Foundation Medicine (FMI) Stock?

                        Investors in Foundation Medicine, Inc. (FMI) need to pay close attention to the stock based on moves in the options market lately.

                          Implied Volatility Surging for Foundation Medicine (FMI) Stock Options

                          Options traders are pricing in a big move for Foundation Medicine (FMI) shares as it has huge implied volatility.

                            What's Behind Clovis' (CLVS) One-Year Rally of 146.3%?

                            In December, Clovis received the FDA nod for its first product, Rubraca, which sent its shares soaring.

                              Foundation Medicine (FMI): Moving Average Crossover Alert

                              Foundation Medicine, Inc. (FMI) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.

                                Clovis Scales 52-Week High on Early FDA Nod for Rubraca

                                Shares of Clovis Oncology (CLVS) touched a 52-week high after the company gained accelerated FDA nod for its advanced ovarian cancer drug, Rubraca.